Sappanone A Targets Transcription Factor EB to Promote Lysosomal Autophagy and Attenuate High Glucose-Induced Myocardial Injury
Pharmacology · 2026
DOI: 10.1159/000551971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology, 2026. Verfasst von Chenchen Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, West Anhui Health Vocational College, Lu'an, China. Hauptthemen laut MEDLINE: Autophagy, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Lysosomes, Diabetic Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Introduction
Diabetic cardiomyopathy (DCM) involves myocardial injury under hyperglycemia, where impaired autophagy and oxidative stress play critical roles. This study explores whether sappanone A (a natural compound) alleviates DCM by activating transcription factor EB (TFEB)-mediated lysosomal autophagy.
Methods
In vitro: H9c2 cardiomyocytes were injured with high glucose (HG) and treated with sappanone A. Cell viability (Cell Counting Kit-8), apoptosis (flow cytometry), reactive oxygen species (ROS; DCFH-DA), and autophagy markers (LC3-II/I, p62, LAMP1 via WB/quantitative real-time PCR) were assessed. In vivo: STZ-induced DCM mice received sappanone A (10 mg/kg/day, 8 weeks). Cardiac function (echocardiography), serum atrial natriuretic peptide/brain natriuretic peptide (enzyme-linked immunosorbent assay), histopathology (H&E/Masson), and autophagy flux (TFEB/LAMP1) were analyzed. TFEB-knockout models and chloroquine (CQ, autophagy inhibitor) validated mechanistic links.
Results
Sappanone A dose-dependently enhanced HG-injured cardiomyocyte survival, reduced apoptosis and ROS, while upregulating TFEB nuclear translocation and lysosomal function. In DCM mice, it improved ejection fraction, reduced fibrosis, and restored autophagic flux. These effects were abolished in TFEB-knockout models or with CQ co-treatment, confirming TFEB-dependent autophagy as the core mechanism.
Conclusion
Sappanone A protects against DCM by activating TFEB-driven lysosomal autophagy, mitigating oxidative stress, and preserving cardiac function. It represents a novel therapeutic candidate for DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, West Anhui Health Vocational College, Lu'an, China.
- Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, China.
- Department of pharmacy, West Anhui Health Vocational College, Lu'an, China.
- Department of Emergency, Changshu Hospital, Soochow University, First People's Hospital of Changshu City, Changshu, China.
- Department of Clinical Medicine, West Anhui Health Vocational College, Lu'an, China, zhangli_wahvc@163.com.
Zitieren
APA
Zhang, C., Zhang, C., Yang, C., & Zhang, L. (2026). Sappanone A Targets Transcription Factor EB to Promote Lysosomal Autophagy and Attenuate High Glucose-Induced Myocardial Injury. Pharmacology. https://doi.org/10.1159/000551971
Vancouver
Zhang C, Zhang C, Yang C, Zhang L. Sappanone A Targets Transcription Factor EB to Promote Lysosomal Autophagy and Attenuate High Glucose-Induced Myocardial Injury. Pharmacology. 2026. doi:10.1159/000551971
BibTeX
@article{Zhang2026,
author = {Zhang, Chenchen and Zhang, Chuanqi and Yang, Caiyun and Zhang, Li},
title = {Sappanone A Targets Transcription Factor EB to Promote Lysosomal Autophagy and Attenuate High Glucose-Induced Myocardial Injury},
journal = {Pharmacology},
year = {2026},
doi = {10.1159/000551971}
}
EUVIMED